[go: up one dir, main page]

WO2019088213A1 - Composition contenant un d-chiro-inositol - Google Patents

Composition contenant un d-chiro-inositol Download PDF

Info

Publication number
WO2019088213A1
WO2019088213A1 PCT/JP2018/040631 JP2018040631W WO2019088213A1 WO 2019088213 A1 WO2019088213 A1 WO 2019088213A1 JP 2018040631 W JP2018040631 W JP 2018040631W WO 2019088213 A1 WO2019088213 A1 WO 2019088213A1
Authority
WO
WIPO (PCT)
Prior art keywords
composition
inositol
chiro
present
monoalcohol
Prior art date
Application number
PCT/JP2018/040631
Other languages
English (en)
Japanese (ja)
Inventor
公輔 田中
Original Assignee
小林製薬株式会社
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 小林製薬株式会社 filed Critical 小林製薬株式会社
Publication of WO2019088213A1 publication Critical patent/WO2019088213A1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34—Alcohols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair

Definitions

  • the present invention relates to a composition comprising D-chiro-inositol.
  • the present invention also relates to an external preparation comprising the composition.
  • Inositol (1,2,3,4,5,6-cyclohexanehexaol) has a structure in which one hydrogen atom on each carbon of cyclohexane is substituted by a hydroxy group, and is known as a vitamin-like substance There is. Inositol has nine stereoisomers depending on the combination of configuration of hydroxy group.
  • Patent Document 1 discloses a hair restorer containing inositol as an active ingredient.
  • inositol used in the prior art refers to myo-inositol (cis-1,2,3,5-trans-4) as an additive for pharmaceuticals, quasi-drugs, cosmetics, etc. , 6-cyclohexanehexaol) is usually meant (see, for example, non-patent documents 1 to 3).
  • D-chiro-inositol is a water-soluble compound among the isomers of inositol.
  • D-chiro-inositol is one of the stereoisomers of inositol in aqueous solution as well. It has been found that it tends to form precipitates.
  • D-chiro-inositol has very low solubility in solvents other than water, and tends to form precipitates more easily in a mixed solution containing solvents other than water.
  • an object of the present invention is to provide a composition capable of suppressing the precipitation of D-chiro-inositol.
  • composition containing D-chiro-inositol and a polyhydric alcohol can suppress precipitation of D-chiro-inositol. It has been found that it is a composition, and the present invention has been completed.
  • a composition comprising D-chiro-inositol and a polyhydric alcohol.
  • composition according to [5] wherein the monoalcohol having 1 to 3 carbon atoms is ethanol.
  • An external preparation comprising the composition according to any one of [1] to [7].
  • a composition capable of suppressing the precipitation of D-chiro-inositol is provided.
  • composition of the present invention is a composition comprising D-chiro-inositol and a polyhydric alcohol.
  • the D-chiro-inositol is not particularly limited.
  • those extracted from naturally occurring oats, beans, citrus and the like, those produced and extracted from leguminous plants by a fermentation method, those synthesized chemically, and A commercial item is mentioned.
  • the method of extraction is not particularly limited, and a known extraction method can be used.
  • the content of D-chiro-inositol in the composition of the present invention is not particularly limited, but is preferably 0.001 to 20 w / v%, more preferably 0.01 to 20 w / v%, and further preferably Is from 0.05 to 15 w / v%, more preferably from 1 to 10 w / v%, even more preferably from 3 to 7 w / v%.
  • w / v% means the weight percentage of D-chiro-inositol relative to the volume of the composition.
  • X to Y means that X is greater than or equal to Y and less than or equal to Y.
  • the composition of the present invention can be used as an external preparation.
  • an agent for cracking and tearing, an agent for heat and air, an agent for skin and octopus, an agent for swelling and skinning, an agent for wrinkles and stains, a moisturizing agent, a hair dye, a hair restorer, a shampoo examples include rinses, conditioners, lotions, creams, emulsions, hand creams, medicinal soaps, packs and the like.
  • the composition of the present invention can obtain a composition having a vitamin-like action or hair growth activity, and may be used as a hair growth agent.
  • the feeling of use in a monoalcohol preparation having 1 to 3 carbon atoms can be improved by containing D-chiro-inositol.
  • the hair growth activity is an activity related to hair shaft growth promotion, hair growth, hair loss prevention and the like, and preferably an activity related to hair trunk growth promotion and hair growth.
  • the composition of the present invention comprises a polyhydric alcohol.
  • a polyhydric alcohol By containing a polyhydric alcohol, it is possible to suppress the precipitation of D-chiro-inositol.
  • the composition of the present invention which contains a polyhydric alcohol, can provide a composition which is excellent in feeling when used on human skin and which is further imparted with antibacterial properties and moisture retention.
  • the polyhydric alcohol means an alcohol having two or more hydroxyl groups in the molecule.
  • the polyhydric alcohol is not particularly limited.
  • glycerin ethylene glycol, diethylene glycol, triethylene glycol, propylene glycol (1,2-propanediol), dipropylene glycol, trimethylolpropane, 1,3-propylene glycol 1,3-propanediol), isobutylene glycol (2-methyl-1,2-propanediol), 1,2-butanediol, 1,3-butylene glycol (1,3-butanediol), 1,4-butane Diol, 2-butene-1,4-diol, 1,2-pentanediol, 1,5-pentanediol, 2-methyl-2,4-pentanediol, 1,2-hexanediol, 1,6-hexanediol , 2-ethyl-1,3-hexanediol, 1 7-heptane-diol, and 1,8-octanediol, and
  • the content of polyhydric alcohol in the composition of the present invention is not particularly limited, but is usually 0.1 w / v% or more, preferably 0.5 w / v% or more, and more preferably 0.5 to 30 w / V%, more preferably 0.5 to 20 w / v%, still more preferably 0.5 to 15 w / v%.
  • the content of polyhydric alcohol in the composition of the present invention may be 1 to 5 w / v%.
  • composition of the present invention may further contain a C 1 to C 3 monoalcohol aqueous solution.
  • a C 1 -C 3 monoalcohol aqueous solution By containing a C 1 -C 3 monoalcohol aqueous solution, the composition of the present invention tends to be able to further suppress the precipitation of D-chiro-inositol.
  • the monoalcohol having 1 to 3 carbon atoms is methanol, ethanol, n-propanol and isopropanol, preferably ethanol and isopropanol, more preferably ethanol.
  • the C 1 to C 3 monoalcohol may be used alone or in combination of two or more.
  • the concentration of the monoalcohol having 1 to 3 carbons in the aqueous monoalcohol having 1 to 3 carbons in the composition of the present invention is not particularly limited, but the concentration of the monoalcohol having 1 to 3 carbons may be set high. It is possible.
  • the concentration of the monoalcohol having 1 to 3 carbons in the aqueous monoalcohol having 1 to 3 carbons may be, for example, 60 v / v% or less, 30 to 70 v / v%, or 30 to 60 v / v%. It may be 30 to 40 v / v%.
  • v / v% means the volume percentage of C 1-3 monoalcohol to the volume of C 1-3 monoalcohol aqueous solution.
  • the C 1 -C 3 monoalcohol aqueous solution is composed of C 1 -C 3 monoalcohol and water. Since the composition of the present invention contains water as a monoalcohol aqueous solution having 1 to 3 carbon atoms, D-chiro-inositol contained in the composition is soluble in water, so that the function and effect of the present invention can be more surely achieved. It tends to be obtainable. Examples of water include pure water such as ion exchange water, ultrafiltered water, reverse osmosis water, and distilled water, and water from which ionic impurities have been removed as much as possible, such as ultrapure water.
  • composition of the present invention may further comprise a monoterpene.
  • the inclusion of the monoterpene tends to impart a refreshing sensation and to obtain an excellent composition by suppressing precipitation of D-chiro-inositol.
  • the monoterpene is not particularly limited, but monoterpene hydrocarbons such as limonene, pinene and camphor; monoterpene alcohols such as citronellol, geraniol, linalool, menthol, terpineol and borneol; monoterpenes such as citronellal, citral and safranal Examples of such aldehydes include monoterpene ketones such as menthone, carbomentone and ionone. It is preferably a monoterpene alcohol, more preferably menthol. These monoterpenes may be any of d-, l- and dl-forms. These may be used alone or in combination of two or more. Especially as menthol, although not particularly limited, for example, 1-menthol and d-menthol are preferable, and 1-menthol is more preferable. It may be used as a mixture of l-menthol and d-menthol.
  • the content of monoterpene in the composition of the present invention is not particularly limited, but is preferably 0.01 to 10 w / v%, more preferably 0.05 to 2 w / v%, still more preferably 0. It is 1 to 1.0 w / v%, and more preferably 0.7 to 1.0 w / v%.
  • composition of the present invention may further contain additives generally accepted for medicines, quasi-drugs, cosmetics and the like.
  • additives are not particularly limited, but, for example, excipients, stabilizers, odorants, bases, dispersants, diluents, surfactants, emulsifiers, percutaneous absorption enhancers, pH adjusters, preservatives, Colorant, oil (oil, fat, mineral oil, etc.), thickener, polymer, film-forming agent, UV absorber, cell activator, antioxidant, preservative, freshener, deodorant, pigment, dye, fragrance, Examples include saccharides, amino acids, vitamins, organic acids, organic amines, plant extracts and the like.
  • the composition of the present invention is not particularly limited, and can be produced by mixing the components included in the present invention.
  • the order in which the components are mixed is not particularly limited.
  • the conditions in the case of mixing are not specifically limited, either, It can be set as the composition of this invention according to a conventionally well-known method.
  • composition of the present invention when used as an external preparation, it can be used as pharmaceuticals, quasi-drugs, cosmetics, etc.
  • it can be used for skin cosmetics, hair cosmetics and scalp cosmetics . More specifically, it may be in the form of an ointment, a pap, liniment, a lotion, a solution for external use, a spray, a cream, a gel, an emulsion, a hair tonic, a hair spray.
  • the method of the present invention comprises the step of administering the composition of the present invention to a subject.
  • the dose of D-chiro-inositol per dose to a subject is not particularly limited, but is preferably 0.005 to 200 mg, more preferably 0.05 to 100 mg, still more preferably 0.5 to It is 10 mg.
  • the number of administrations of the composition of the present invention to a subject is not particularly limited, but is preferably 1 to 6 times per day, more preferably 1 to 3 times per day, and still more preferably 1 It is ⁇ 2 times.
  • composition of the present invention is administered is not particularly limited, and includes, for example, humans, animals such as domestic animals and pets, and the like.
  • DCI D-chiro-inositol
  • Ethanol manufactured by Wako Pure Chemical Industries, Ltd., hereinafter abbreviated as "EtOH”
  • Glycerin manufactured by Wako Pure Chemical Industries, Ltd.
  • each component was diluted and mixed with pure water so as to obtain the compositions shown in Tables 1 and 2 below, and each composition was prepared as a formulation.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Birds (AREA)
  • Emergency Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Dermatology (AREA)
  • Cosmetics (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

L'invention fournit une composition permettant d'inhiber un dépôt de D-chiro-inositol. Plus précisément, l'invention concerne une composition contenant un D-chiro-inositol et un polyalcool.
PCT/JP2018/040631 2017-11-01 2018-11-01 Composition contenant un d-chiro-inositol WO2019088213A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2017-212257 2017-11-01
JP2017212257A JP7450324B2 (ja) 2017-11-01 2017-11-01 Ｄ－ｃｈｉｒｏ－イノシトールを含む組成物

Publications (1)

Publication Number Publication Date
WO2019088213A1 true WO2019088213A1 (fr) 2019-05-09

Family

ID=66333247

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2018/040631 WO2019088213A1 (fr) 2017-11-01 2018-11-01 Composition contenant un d-chiro-inositol

Country Status (2)

Country Link
JP (1) JP7450324B2 (fr)
WO (1) WO2019088213A1 (fr)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2020147541A (ja) * 2019-03-14 2020-09-17 小林製薬株式会社 外用組成物
FR3104421A1 (fr) * 2019-12-17 2021-06-18 L V M H Recherche Composition cosmétique comprenant du D-chiro-inositol

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7519753B2 (ja) * 2018-06-29 2024-07-22 小林製薬株式会社 Ｄ－ｃｈｉｒｏ－イノシトールを含む組成物
JP7203521B2 (ja) * 2018-06-29 2023-01-13 小林製薬株式会社 Ｄ－ｃｈｉｒｏ－イノシトールを含む組成物
JP7580183B2 (ja) * 2018-06-29 2024-11-11 小林製薬株式会社 Ｄ－ｃｈｉｒｏ－イノシトールを含む組成物
JP7203522B2 (ja) * 2018-06-29 2023-01-13 小林製薬株式会社 Ｄ－ｃｈｉｒｏ－イノシトールを含む組成物

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020143039A1 (en) * 2000-02-23 2002-10-03 Orentreich Foundation For The Advancement Of Science, Inc. Methods and compositions for the treatment of alopecia and other disorders of the pilosebaceous apparatus
JP2002542295A (ja) * 1999-04-27 2002-12-10 インスメッド ファーマシューティカルズ， インコーポレイテッド 哺乳動物において、インスリン感受性およびグルコース代謝を改善する組成物および方法
JP2006028026A (ja) * 2004-07-12 2006-02-02 Doctor Program Kk 育毛剤
JP2006521291A (ja) * 2003-03-26 2006-09-21 アミコーゲン インコーポレイテッド 肝保護のためのピニトールまたはカイロイノシトールの使用

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002542295A (ja) * 1999-04-27 2002-12-10 インスメッド ファーマシューティカルズ， インコーポレイテッド 哺乳動物において、インスリン感受性およびグルコース代謝を改善する組成物および方法
US20020143039A1 (en) * 2000-02-23 2002-10-03 Orentreich Foundation For The Advancement Of Science, Inc. Methods and compositions for the treatment of alopecia and other disorders of the pilosebaceous apparatus
JP2006521291A (ja) * 2003-03-26 2006-09-21 アミコーゲン インコーポレイテッド 肝保護のためのピニトールまたはカイロイノシトールの使用
JP2006028026A (ja) * 2004-07-12 2006-02-02 Doctor Program Kk 育毛剤

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2020147541A (ja) * 2019-03-14 2020-09-17 小林製薬株式会社 外用組成物
JP7350498B2 (ja) 2019-03-14 2023-09-26 小林製薬株式会社 外用組成物
JP7570469B2 (ja) 2019-03-14 2024-10-21 小林製薬株式会社 外用組成物
FR3104421A1 (fr) * 2019-12-17 2021-06-18 L V M H Recherche Composition cosmétique comprenant du D-chiro-inositol
WO2021123624A1 (fr) * 2019-12-17 2021-06-24 L V M H Recherche Composition cosmétique comprenant du d-chiro-inositol

Also Published As

Publication number Publication date
JP2019085342A (ja) 2019-06-06
JP7450324B2 (ja) 2024-03-15

Similar Documents

Publication Publication Date Title
WO2019088213A1 (fr) Composition contenant un d-chiro-inositol
WO2019088211A1 (fr) Composition contenant un d-chiro-inositol
CN101203277A (zh) 毛发滋补剂
CN105963151A (zh) 一种不含防腐剂的化妆品防腐用组合物
JP7519753B2 (ja) Ｄ－ｃｈｉｒｏ－イノシトールを含む組成物
JP7570469B2 (ja) 外用組成物
JP2002332240A (ja) 育毛剤組成物
JP7127979B2 (ja) Ｄ－ｃｈｉｒｏ－イノシトールを含む組成物
CN107427430A (zh) 不饱和脂肪氧化的硝酮抑制
JP7203521B2 (ja) Ｄ－ｃｈｉｒｏ－イノシトールを含む組成物
JP7203522B2 (ja) Ｄ－ｃｈｉｒｏ－イノシトールを含む組成物
JP2003313113A (ja) 育毛剤
JP4495979B2 (ja) 頭皮頭髪化粧料
JP7580183B2 (ja) Ｄ－ｃｈｉｒｏ－イノシトールを含む組成物
EP2866787A2 (fr) Huile essentielle de marjolaine, composition comprenant ladite huile, méthode de traitement cosmétique et utilisation
KR102587124B1 (ko) 보습성 및 롤링성이 향상된 마사지용 화장료 조성물 및 이를 포함하는 젤
WO2023099791A1 (fr) Nouvelles compositions comprenant du trans-rétinol
JP7594344B2 (ja) 外用組成物
JP2014015422A (ja) 化粧料組成物
JP4044988B2 (ja) 化粧料
EP4512387A1 (fr) Composition de gel de parfum
JP2019151610A (ja) 薬用を含む化粧品原材料、化粧品基剤および化粧品
JP2002370921A (ja) 化粧料組成物
CN106573025B (zh) 包含金纽扣提取物的局部用组合物及其用途
JP2020023581A (ja) 外用組成物

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 18872233

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 18872233

Country of ref document: EP

Kind code of ref document: A1